Published in Obesity and Diabetes Week, May 22nd, 2006
According to a study from Italy, "A potential approach to the treatment of morbid obesity is reduction of gastric emptying to achieve satiety. Botulinum toxin A (Btx-A) is a long-acting inhibitor of acetylcholine-mediated peristalsis, which is mainly responsible for gastric motility."
D. Gui and colleagues working with Universita Cattolica del Sacro Cuore proposed, "To investigate whether botulinum toxin A, injected in the antrum of obese patients, delays...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week